2 Nov 2026

BioRider takes another step towards orbit

We’re proud to announce the signature of a Memorandum of Understanding (MoU) with the European Space Agency (ESA) for the potential deployment of BioRider on Space Rider first flight.

This milestone represents a key step forward in securing in-orbit and return capabilities for life science and biotech experiments, made possible thanks to the Italian Space Agency (ASI), whose funding is enabling the development of the BioRider facility and the implementation of the first set of experiments on the maiden flight of Space Rider.

As with any complex space mission, this is the first important step… the definitive confirmation will come with the Flight Service Agreement (FSA).

What is Biorider?

BioRider is a key platform for post-ISS life science, microgravity research and in-orbit validation. Leveraging Space Rider’s unique capabilities, is designed to unlock a new standard for space-based experimentation:

  • Life science & biotechonology experiment hosting – potential integration as late as possible (late access)
  • Fast re-entry & Very early retrieval landing – samples back quickly, critical advantage for sensitive biology.

On the Space Rider’s first flight, BioRider will host three experiments ranging from astrobiology and exobiology (CyanoTechRider, University of Rome Tor Vergata) to cell and developmental biology (Aquarius, Scuola Superiore Sant’Anna), and to nutraceuticals and pharmacology (Exovector, Rizzoli Orthopedic Institute).

We are now starting to shape the next experiment opportunities offering an end-to-end service exploiting the BioRider facility on future Space Rider missions.

If you are working on:

  • biotech, pharma or synthetic biology
  • organ-on-chip and microfluidics
  • advanced materials or space-enabled R&D

is the time to get in touch for upcoming BioRider flights.. info.biorider@kayser.space!